Clinical Trial Update: Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pemetrexed + cisplatin + enzastaurin vs pemetrexed + cisplatin + placebo in advanced/metastatic lung cancer was terminated; results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Enzastaurin (enzastaurin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-11-05